Phase II Study of Abemaciclib Pembrolizumab in KRAS Mutated PD L1 Stage IV Chemonaïve Non Small Cell Lung Cancer and in Pretreated Squamous Cell Lung Cance
Bildiriler > Özet Bildiri · 2016
Yazarlar: J MAZİERES, S TOLANEY, L PAZARES, Tuncay GÖKSEL, CC LİN, A HOSSAİN, W JOHN, P KABOS
World Conference on Lung Cancer, Avusturya, Uluslararası, Poster, Özet Bildiri, 2016-2016